legal-news
2:26-cv-03509 ULTRAGENYX PHARMACEUTICAL INC. et al v. SOMERSET THERAPEUTICS LLC et al
scheduleUpdated 21 hours ago
26-cv-03509
|
|
Filed
Advertisement
description
Case Summary
This case involves corporate disclosure statements filed by Ultragenyx Pharmaceutical Inc. and Somerset Therapeutics LLC in docket 26-cv-03509. The summary indicates that the corporate disclosure statement (aty) has been submitted, but further details about the content and legal significance are not provided.
Stage
Active litigation
Timeline
1 event
Coverage
1 article
Sources
1
Key Issues
- • Corporate disclosure statement
- • Ultragenyx Pharmaceutical Inc
- • Somerset Therapeutics LLC
update What Changed This Week
1 event
1 article
newspaper
pacer
22 hours, 10 minutes ago
2:26-cv-03509 ULTRAGENYX PHARMACEUTICAL INC. et al v. SOMERSET THERAPEUTICS LLC
info
Other
22 hours, 35 minutes ago
2:26-cv-03509 ULTRAGENYX PHARMACEUTICAL INC. et al v. SOMERSET THERAPEUTICS LLC
Advertisement
Case Timeline
1 event
info
Other
April 16, 2026
2:26-cv-03509 ULTRAGENYX PHARMACEUTICAL INC. et al v. SOMERSET THERAPEUTICS LLC et al
In a corporate legal matter, Ultragenyx Pharmaceutical Inc. and Somerset Therapeutics LLC are involved in a case that requires a disclosure statement, specifically a 10-K filing, which is a comprehensive report on a company's financial performance and operations.
Advertisement
show_chart
Coverage Timeline
newspaper
1 article